Amylyx Pharmaceuticals IncNASDAQ:AMLX
- LAST PRICE2.9400
- TODAY'S CHANGE (%)-0.0900 (-2.9703%)
- Bid / Lots2.9100/ 18
- Ask / Lots2.9800/ 21
- Open / Previous Close3.0100 / 3.0300
- Day Range
- 52 Week Range
- Volume788,751
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMLX |
|---|---|---|
| 09:32 ET | 4947 | 2.99 |
| 09:34 ET | 600 | 3 |
| 09:36 ET | 22076 | 3.04 |
| 09:38 ET | 5100 | 3.04 |
| 09:39 ET | 2543 | 3.04 |
| 09:41 ET | 6275 | 3.0144 |
| 09:43 ET | 3874 | 2.995 |
| 09:45 ET | 3003 | 3 |
| 09:50 ET | 1475 | 3.002 |
| 09:52 ET | 1000 | 3.005 |
| 09:54 ET | 2900 | 3.02 |
| 09:56 ET | 1122 | 3.03 |
| 09:57 ET | 1300 | 3.035 |
| 09:59 ET | 600 | 3.035 |
| 10:01 ET | 6821 | 3.035 |
| 10:03 ET | 1200 | 3.05 |
| 10:06 ET | 1100 | 3.055 |
| 10:08 ET | 1239 | 3.0559 |
| 10:10 ET | 400 | 3.055 |
| 10:12 ET | 900 | 3.055 |
| 10:14 ET | 600 | 3.055 |
| 10:15 ET | 3757 | 3.025 |
| 10:17 ET | 2050 | 3.025 |
| 10:19 ET | 3780 | 3.045 |
| 10:21 ET | 2600 | 3.035 |
| 10:24 ET | 4661 | 3.035 |
| 10:26 ET | 1486 | 3.025 |
| 10:28 ET | 1500 | 3.025 |
| 10:30 ET | 400 | 3.02 |
| 10:32 ET | 4468 | 3.04 |
| 10:33 ET | 12867 | 3.07 |
| 10:35 ET | 2283 | 3.065 |
| 10:37 ET | 1937 | 3.07 |
| 10:39 ET | 2577 | 3.05 |
| 10:42 ET | 1200 | 3.035 |
| 10:44 ET | 1065 | 3.025 |
| 10:46 ET | 3000 | 3.02 |
| 10:48 ET | 2088 | 3.015 |
| 10:50 ET | 700 | 3.015 |
| 10:51 ET | 1200 | 3.005 |
| 10:53 ET | 3357 | 2.995 |
| 10:55 ET | 1700 | 2.995 |
| 10:57 ET | 1216 | 2.995 |
| 11:00 ET | 700 | 2.995 |
| 11:02 ET | 1700 | 2.995 |
| 11:04 ET | 2399 | 2.995 |
| 11:06 ET | 2600 | 3 |
| 11:08 ET | 1098 | 2.995 |
| 11:09 ET | 2110 | 2.991 |
| 11:11 ET | 9555 | 2.99 |
| 11:13 ET | 500 | 2.995 |
| 11:15 ET | 600 | 2.995 |
| 11:18 ET | 1894 | 3.005 |
| 11:20 ET | 2682 | 3.01 |
| 11:22 ET | 400 | 3.01 |
| 11:24 ET | 696 | 3.01 |
| 11:26 ET | 1200 | 3.015 |
| 11:27 ET | 800 | 3.02 |
| 11:29 ET | 1200 | 3.015 |
| 11:31 ET | 300 | 3.015 |
| 11:33 ET | 2071 | 3.015 |
| 11:36 ET | 500 | 3.015 |
| 11:38 ET | 400 | 3.015 |
| 11:40 ET | 200 | 3.015 |
| 11:42 ET | 400 | 3.02 |
| 11:44 ET | 948 | 3.015 |
| 11:45 ET | 748 | 3.015 |
| 11:47 ET | 2110 | 3.015 |
| 11:49 ET | 696 | 3.02 |
| 11:51 ET | 302 | 3.015 |
| 11:54 ET | 1600 | 3.01 |
| 11:56 ET | 3109 | 3.005 |
| 11:58 ET | 2293 | 3.015 |
| 12:00 ET | 1666 | 3.02 |
| 12:02 ET | 640 | 3.0111 |
| 12:03 ET | 1110 | 3.015 |
| 12:05 ET | 3644 | 3.005 |
| 12:07 ET | 3826 | 3.035 |
| 12:09 ET | 2216 | 3.03 |
| 12:12 ET | 200 | 3.03 |
| 12:14 ET | 2155 | 3.04 |
| 12:16 ET | 1392 | 3.035 |
| 12:18 ET | 700 | 3.035 |
| 12:20 ET | 200 | 3.035 |
| 12:21 ET | 523 | 3.04 |
| 12:23 ET | 1505 | 3.04 |
| 12:25 ET | 200 | 3.05 |
| 12:27 ET | 400 | 3.045 |
| 12:30 ET | 1610 | 3.04 |
| 12:32 ET | 8122 | 3.04 |
| 12:34 ET | 5373 | 3.055 |
| 12:36 ET | 1000 | 3.06 |
| 12:38 ET | 400 | 3.055 |
| 12:39 ET | 4427 | 3.06 |
| 12:41 ET | 1800 | 3.07 |
| 12:43 ET | 800 | 3.06 |
| 12:45 ET | 1810 | 3.055 |
| 12:48 ET | 400 | 3.055 |
| 12:50 ET | 519 | 3.06 |
| 12:52 ET | 2248 | 3.05 |
| 12:54 ET | 200 | 3.045 |
| 12:56 ET | 2195 | 3.03 |
| 12:57 ET | 462 | 3.035 |
| 12:59 ET | 1436 | 3.035 |
| 01:01 ET | 300 | 3.035 |
| 01:03 ET | 2153 | 3.05 |
| 01:06 ET | 1576 | 3.05 |
| 01:10 ET | 100 | 3.05 |
| 01:12 ET | 400 | 3.045 |
| 01:14 ET | 420 | 3.045 |
| 01:15 ET | 838 | 3.05 |
| 01:17 ET | 872 | 3.06 |
| 01:19 ET | 3361 | 3.055 |
| 01:21 ET | 300 | 3.055 |
| 01:24 ET | 300 | 3.05 |
| 01:26 ET | 9586 | 3.055 |
| 01:28 ET | 1813 | 3.05 |
| 01:30 ET | 2977 | 3.03 |
| 01:32 ET | 2007 | 3.025 |
| 01:33 ET | 400 | 3.03 |
| 01:35 ET | 400 | 3.03 |
| 01:37 ET | 400 | 3.025 |
| 01:39 ET | 1342 | 3.025 |
| 01:44 ET | 7803 | 3.0009 |
| 01:46 ET | 1300 | 3.005 |
| 01:48 ET | 24705 | 2.99 |
| 01:50 ET | 1195 | 2.985 |
| 01:51 ET | 2792 | 2.99 |
| 01:53 ET | 2961 | 2.985 |
| 01:55 ET | 400 | 2.99 |
| 01:57 ET | 4852 | 2.995 |
| 02:00 ET | 14040 | 2.985 |
| 02:02 ET | 500 | 2.981 |
| 02:04 ET | 1817 | 2.985 |
| 02:06 ET | 5342 | 2.995 |
| 02:08 ET | 1317 | 2.9992 |
| 02:09 ET | 1000 | 3 |
| 02:11 ET | 3072 | 3.005 |
| 02:13 ET | 1372 | 3.01 |
| 02:15 ET | 300 | 3.01 |
| 02:22 ET | 200 | 3.005 |
| 02:24 ET | 4361 | 3.005 |
| 02:26 ET | 100 | 3.01 |
| 02:27 ET | 100 | 3.005 |
| 02:29 ET | 603 | 3.01 |
| 02:31 ET | 200 | 3.005 |
| 02:33 ET | 703 | 3.005 |
| 02:36 ET | 3900 | 3.005 |
| 02:38 ET | 8767 | 2.99 |
| 02:40 ET | 2326 | 3 |
| 02:42 ET | 100 | 2.995 |
| 02:44 ET | 768 | 3 |
| 02:45 ET | 997 | 3 |
| 02:47 ET | 7624 | 2.995 |
| 02:49 ET | 24887 | 2.99 |
| 02:51 ET | 767 | 2.99 |
| 02:54 ET | 400 | 2.99 |
| 02:56 ET | 734 | 2.99 |
| 02:58 ET | 100 | 2.99 |
| 03:00 ET | 12047 | 2.975 |
| 03:02 ET | 4728 | 2.97 |
| 03:03 ET | 5061 | 2.965 |
| 03:05 ET | 3266 | 2.955 |
| 03:07 ET | 1042 | 2.955 |
| 03:09 ET | 31526 | 2.955 |
| 03:12 ET | 1400 | 2.955 |
| 03:14 ET | 300 | 2.955 |
| 03:16 ET | 19632 | 2.965 |
| 03:18 ET | 7406 | 2.97 |
| 03:20 ET | 3170 | 2.97 |
| 03:21 ET | 3132 | 2.955 |
| 03:23 ET | 6109 | 2.93 |
| 03:25 ET | 624 | 2.935 |
| 03:27 ET | 1100 | 2.94 |
| 03:30 ET | 4524 | 2.93 |
| 03:32 ET | 700 | 2.935 |
| 03:34 ET | 1238 | 2.935 |
| 03:36 ET | 2264 | 2.93 |
| 03:38 ET | 1391 | 2.935 |
| 03:39 ET | 1700 | 2.94 |
| 03:41 ET | 2926 | 2.935 |
| 03:43 ET | 10693 | 2.945 |
| 03:45 ET | 3562 | 2.96 |
| 03:48 ET | 5634 | 2.955 |
| 03:50 ET | 3791 | 2.945 |
| 03:52 ET | 3324 | 2.945 |
| 03:54 ET | 11857 | 2.92 |
| 03:56 ET | 18030 | 2.93 |
| 03:57 ET | 13409 | 2.94 |
| 03:59 ET | 75164 | 2.94 |
Today
Sep 16, 2024
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm, from 11:42AM ET on Monday Sep 16, 2024 by Dow Jones
11:42AM ET on Monday Sep 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amylyx Pharmaceuticals Inc | 206.3M | -1.2x | --- |
Organogenesis Holdings Inc | 377.8M | -22.9x | --- |
Amarin Corporation PLC | 248.2M | -7.2x | --- |
Sinovac Biotech Ltd | 639.9M | -4.9x | --- |
Ironwood Pharmaceuticals Inc | 680.5M | 97.9x | --- |
Coherus BioSciences Inc | 117.5M | -2.6x | --- |
Company Information
Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate: AMX0035 for the treatment of Wolfram syndrome and for the treatment of progressive supranuclear palsy, and AMX0114, the Company’s antisense oligonucleotide targeting calpain-2 for the treatment of amyotrophic lateral sclerosis (ALS). AMX0035 is a dual-unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). The Company’s Avexitide is an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist that has been evaluated in five clinical trials for post-bariatric hypoglycemia (PBH) and has also been studied in congenital hyperinsulinism (HI), two indications characterized by hyperinsulinemic hypoglycemia.
Contact Information
- Headquarters
- 43 THORNDIKE STREETCAMBRIDGE, MA, United States 02141
- Phone
- 617-682-0917
- Fax
- 302-636-5454
Executives
- Chair of the Board of Directors
- George Milne
- Co-Chief Executive Officer, Director
- Joshua Cohen
- Co-Chief Executive Officer, Director
- Justin Klee
- Chief Financial Officer
- James Frates
- Chief Legal Officer and General Counsel
- Gina Mazzariello
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $206.3M |
|---|---|
Revenue (TTM) | $298.8M |
Shares Outstanding | 68.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.45 |
Book Value | $6.40 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | 0.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -59.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
